Home
Bailly-Creat

Bailly-Creat Market Share Analysis for May 2026

Bailly-Creat is a french pharmaceutical company specialized in the manufacturing and production of dry forms drugs.

Industry: N/A

Domainbaillycreat.com

Year Founded1908

Employees51 - 200

Annual Revenue--

Bailly-Creat

Bailly-Creat (including company regionals)

baillycreat.com

See more website traffic and engagement information

Total visits to Bailly-Creat's top domains

Understand Bailly-Creat market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

baillycreat.com1.8K

See more with Sales Intelligence

Avg. visit duration in Bailly-Creat's top domains

Analyze Bailly-Creat engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

baillycreat.com00:01:47

See more with Sales Intelligence

Avg. pageviews on Bailly-Creat's top domains

See how Bailly-Creat keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

baillycreat.com2.61

See more with Sales Intelligence

Bailly-Creat top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Bailly-Creat

These are the website technologies, by industry, used by Bailly-Creat top domains

Payment & Currencies (21)

PayPal

Widget (7)

Twemoji

Advertising (2)

Google Adsense

Conversion & Analytics (2)

Google Analytics

More Technologies

7

See all

News & Signals from Bailly-Creat

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBailly Creat launched Ibuprofen, Desloratadine, and Amoxicillin + Clavulanic Acid products in the Kingdom on Oct 26th '22.Bailly Creat on October 26 launched its Ibuprofen, Desloratadine, and Amoxicillin + Clavulanic Acid products in the Kingdom through its distribution partner Zuellig Pharma, one of the largest healthcare services groups in Asia.